Virox™ is pleased to announce that several of our Accelerated Hydrogen Peroxide® (AHP®) wipe formulations have been validated by independent testing and proven efficacious against SARS-CoV-2, the virus that causes COVID-19 disease. As industry leaders in infection prevention, our mission is to ensure our customers are protected against the threat of emerging disease outbreaks in all of the markets we serve.
As COVID-19 began to spread worldwide, public health officials issued recommendations to practice physical distancing, regular hand hygiene and cleaning and disinfection to prevent the spread of the SARS-CoV-2 virus. In the event of outbreaks caused by emerging viral pathogens, both the EPA and Health Canada rely on their Emerging Viral Pathogen policies to determine the expected effectiveness of disinfectants against a newly identified virus. All Virox AHP-based formulations meet the criteria for emerging viral pathogens, and can be found on the list of approved disinfectants for both Canada and the United States for use against SARS-CoV-2. The recent testing provides an added layer of confidence that AHP-based formulations have directly demonstrated the ability to kill SARS-CoV-2 and will be submitted to both the EPA and Health Canada for review and approval at which time product labels and marketing materials will be updated.
Since the SARS outbreak hit North America in 2003, Virox has been at the forefront in the fight against infectious disease outbreaks. With an initial focus in human healthcare, Virox has brought safer, more environmentally-responsible disinfectants into a wide range of other industries, including animal health, dental, professional beauty, life sciences, mold remediation and beyond. In addition to developing innovative disinfectant technologies, we are equally committed to providing education and technical support to help facilities optimize their infection prevention protocols.
Please visit our dedicated coronavirus website page to learn more about how we can help you protect your facility against the threat of COVID-19.
Randy Pilon, founder of Virox Technologies Inc., is pleased about a major investment that will allow his company to boost disinfectants production. – Oakville Chamber of Commerce photo
The Ontario government is providing $850,000 to an Oakville manufacturer to help that company increase production of disinfectants needed to fight the spread of the coronavirus.
Vic Fedeli, Minister of Economic Development, Job Creation and Trade, recently announced that Virox Technologies Inc., would be the first company to receive an investment from the Ontario Together Fund.
The money will allow Virox to double its production of disinfectants and create more jobs.
“We are looking for the best and brightest in the province to step up and provide critical goods and services in our effort to stop the spread of COVID-19,” said Fedeli, in a press release.
“I am pleased to see an innovative disinfectant company like Virox Technologies come forward and use its made-in Ontario advanced technology to help keep our front-line workers and communities safe.”
In a speech at Queen’s Park, Ontario Premier Doug Ford noted Virox had created a disinfectant, which kills coronavirus within 30 seconds on any surface.
Virox President and CEO Randy Pilon said his company is planning to install a high-speed manufacturing assembly line to increase production of its Accelerated Hydrogen Peroxide products.
He estimates the new equipment will allow the company to produce 6,000 cases per day, which will help meet increased demand from the health-care sector and general consumer market during the outbreak.
The project will also create 20 full-time and part-time jobs and help retain 120 positions in Oakville.
“We are pleased to respond to the government’s call to action to help stop the spread of this outbreak,” said Pilon in a news release.
“We pride ourselves on offering sustainable hydrogen-peroxide based disinfecting solutions and making products that are safe for people, animals and the planet. By ramping up our production with new equipment and upgrades, we will help meet the growing need in hospitals, and communities across Ontario and Canada.”
On March 21, Ford launched the Ontario Together web portal appealing to Ontario’s manufacturers, entrepreneurs and innovators to provide essential supplies and equipment to support front-line workers in their fight against the COVID-19 pandemic.
To support the development of proposals submitted by businesses and individuals through the Ontario Together web portal and help businesses retool their operations, the government launched a $50 million Ontario Together Fund.
Officials said all submissions received through the portal are being reviewed and prioritized to focus on solutions that can respond to where the need is greatest and can be implemented quickly.
Virox Technologies Inc., was founded in 1998 and is located at 2770 Coventry Rd., in Oakville.
Virox Technologies Inc. is proud to have teamed up with Knix and the Robert Kerr Foundation to donate Accelerated Hydrogen Peroxide® surface disinfectants to help support the homeless and shelters in the GTA. We are happy to do our part during these difficult times.
Ontario Funds Innovative Company to Help Fight COVID-19
Investment will Protect People, Frontline Workers and Communities
NEWS – May 6, 2020
TORONTO – The Ontario government is providing Virox Technologies Inc. with $850,000 from the Ontario Together Fund to help the local manufacturer double its production of disinfectants and create jobs. The investment will assist in keeping people, frontline workers and communities safe and stop the spread of COVID-19. Virox is the first manufacturer to receive money from the Ontario Together Fund.
The announcement was made today by Vic Fedeli, Minister of Economic Development, Job Creation and Trade.
Virox® Technologies Inc earns LEED® Gold Certification
“We officially produce the Greenest, Safest and Most Effective Disinfectants!”
Oakville, ON – In 2012, Virox was the first chemical manufacturer in Canada to earn LEED® Silver certification. Today, Virox Technologies Inc is proud to announce that amidst the COVID-19 Pandemic and working tirelessly to meet demands for our patented disinfectants, we have achieved LEED® Gold certification from the U.S. Green Building Council (USGBC). This certification applies to our 65,958 square foot headquarters which includes the company’s corporate offices, research & development laboratory, manufacturing and warehousing facility.
Virox’s sole focus is engineering revolutionary disinfectants in the war against pathogens. Our patented formulations are not a mere alternative to current disinfectants but game-changing technology platforms with demonstrable superiority over legacy disinfectant chemistries. Virox® is dedicated to the development (Innovate), optimization (Formulate), adoption (Educate) and acceptance (Validate) of a fundamentally new approach to disinfection that has been reviewed and endorsed by third party authorities, the scientific community, official regulatory bodies and key opinion leaders in a broad range of industries. Those industries include human and animal health markets around the globe in over 70 countries.
To help upgrade their LEED certification, Virox hired an external consulting team. Developed by USGBC, LEED® (Leadership in Energy and Environmental Design) is an internationally recognized green building certification system that provides third party verification that a building was designed and built using strategies aimed at improving performance in key environmental areas.
When asked why a chemical manufacturer would want to undertake such a challenge, Randy Pilon, President and CEO stated, “It’s the right thing to do. I challenged the team to achieve LEED certification and through the process we created a company that has completely changed its culture and embraced the challenge of being the greenest of the green with such a passion that we achieved LEED Gold status. It seemed only fitting that if we develop and manufacture certified green products, we should do so in a certified green building.”
Source: Virox Technologies Inc.
For further information:
John Van Dyke
Senior Vice President, Corporate Affairs
As news of the COVID-19 pandemic continues, it can be easy to overlook the current steps you have in place to ensure you and your team stay healthy. To prevent the spread of infection in your cannabis facility, it’s essential to review and optimize your infection prevention strategies.
Read free version of article here.
NATIONAL POST, March 31, 2020: Zoonotic pathogens, like the coronavirus causing COVID-19, are infectious microorganisms that can spread between humans and animals. These pathogens present concerns for disease outbreaks, since previously-unknown viruses have the potential to jump from wildlife into the human population with little or no warning. Although most strains of coronavirus only cause the common cold, two particular stains have been responsible for more severe diseases prior to the identification of COVID-19: severe acute respiratory syndrome (SARS-CoV) in 2002-2003 and Middle East respiratory syndrome (MERS-CoV), first reported in 2012.
Read free version of article here.
Global’s Minna Rhee gets an inside glimpse at Virox and the technology that kills COVID-19 in under 1 minute with no odour or volatility.
“Our competition is not brands, it is legacy chemistries, chemicals that have been used for decades, sometimes 50, 60 years that have remained unchanged. All the while the bugs are mutating but the chemicals stayed the same. So it’s not terribly difficult to disinfect a surface. It’s difficult to disinfect a surface without hurting the surface or the person doing it and the environment post use.
…If you take a look at SARS from 2003 and you take a look at where we are today there’s been a number of mini outbreaks in between there. So you had MERS in the Middle East. Again, another virus transmitted from an animal. And then in between there you’ve had community outbreaks of MRSA, VRE, the infection prevention experts call it the bug of the week club. They do not expect that this is the end. This is just possibly the new norm. All of this activity will make people more prepared, more aware, and you’re gonna see different procedures, processes put in place in terms of state of readiness.”
RANDY PILON, President and CEO, Virox Technologies Inc. March 23, 2020